| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 15.283 | 0 | 58.727 | 0 | 0 | - | - | - |
| Total Income - EUR | - | - | 15.286 | 0 | 58.817 | 0 | 0 | - | - | - |
| Total Expenses - EUR | - | - | 12.094 | 232 | 12.306 | 1.088 | 363 | - | - | - |
| Gross Profit/Loss - EUR | - | - | 3.191 | -232 | 46.511 | -1.088 | -363 | - | - | - |
| Net Profit/Loss - EUR | - | - | 2.733 | -232 | 44.749 | -1.088 | -363 | - | - | - |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | - | - | - |
Check the financial reports for the company - Totpharma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 13 | 0 | 0 | 0 | 0 | - | - | - |
| Current Assets | - | - | 2.767 | 2.519 | 47.413 | 46.136 | 44.563 | - | - | - |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Receivables | - | - | 0 | 8 | 21.629 | 21.224 | 20.755 | - | - | - |
| Cash | - | - | 2.767 | 2.511 | 25.785 | 24.912 | 23.808 | - | - | - |
| Shareholders Funds | - | - | 2.777 | 2.516 | 47.216 | 45.233 | 43.867 | - | - | - |
| Social Capital | - | - | 44 | 64 | 63 | 62 | 61 | - | - | - |
| Debts | - | - | 3 | 3 | 198 | 903 | 696 | - | - | - |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Totpharma S.r.l.